TMG (Trimethylglycine / Betaine)

Research Reliability -

A methyl donor involved in homocysteine metabolism. Replenishes methyl groups consumed by NAD+ precursors, creatine, and other methylation-heavy stacks.

Appetite

Mood

Sleep

TMG (Trimethylglycine / Betaine)
TMG (Trimethylglycine / Betaine)

Description

Trimethylglycine donates methyl groups directly to homocysteine, converting it back to methionine via the betaine-homocysteine methyltransferase pathway — an alternative route to the folate/B12-dependent methylation cycle. It is a quiet workhorse in biohacking stacks because high-dose NAD+ precursors, creatine, and phosphatidylcholine all consume methyl groups during their own metabolism, and TMG helps prevent the resulting depletion. Clinical use also includes supporting liver health in non-alcoholic fatty liver disease, where it reduces fat accumulation in hepatocytes.

Effects
First 2 weeks

subtle

Weeks 2–4

homocysteine drops on labs; some notice steadier energy or workout output

homocysteine drops on labs; some notice steadier energy or workout output

Ongoing

methylation support, pairs with B-vitamins

methylation support, pairs with B-vitamins

How It Feels

Mostly a methylation supporter measured by homocysteine on labs, though some people notice a mild boost in energy or gym performance. It is often stacked with NMN to offset methylation demand. Gentle and well tolerated.

Evidence

Evidence Strength

Moderate (some human RCTs)

Caveats

Homocysteine-lowering effect is well established; evidence for athletic performance benefits is more preliminary and mixed.

Usage
Commonly Referenced Starting Amount

500 mg/day

Commonly Referenced Amount

500 mg to 6 g/day covers the range used in homocysteine-lowering research

Referenced Upper Limit

No formal upper limit has been established, but higher doses have been associated with a rise in LDL and total cholesterol — worth tracking lipids if using it at the higher end long-term

Onset

2–4 weeks (homocysteine)

Biomarkers to Track
Subjective

(Daily)

  1. Energy and mental clarity (1–10)

  2. Liver and digestive comfort

  3. Mood stability

Objective

(Quarterly)

  1. Homocysteine level

  2. Liver enzymes (ALT, AST)

  3. Lipid panel

Risks
Risks
Risks

Generally safe. It lowers homocysteine and pairs well with methylation-demanding compounds.

Who Should Skip
Who Should Skip
Who Should Skip

People with kidney disease should check first.

Common Mistakes
Common Mistakes
Common Mistakes

Overlooking it as an NMN companion, and expecting a strong felt effect.

Disclaimer

This information is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.

Citations
Citations
Citations

Olthof MR, Verhoef P (2005). Current Drug Metabolism. Review (betaine and homocysteine metabolism). PMID: 15975043.

The content on this site is provided for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. Aambrosia sells subscription access to editorial and research content only, no supplement, compound, or other physical product discussed on this site is sold, shipped, or dispensed by Aambrosia. Always consult a qualified healthcare provider before making changes to your diet, supplement routine, or health practices. Aambrosia does not guarantee specific results, and individual outcomes may vary

Business Address: Dunn Dr, Culver City, CA, 90232
Support: support@aambrosia.com